JM
Jason McCarthy Maxim Group Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
AIM
26
AIM ImmunoTech Inc.
AIM
$7.02M
| $2.57 | $1 |
61%
downside
| Buy |
22 Oct ‘24
10 months ago |
|
27
Capricor Therapeutics
CAPR
$290M
| $6.48 | $25 |
286%
upside
| Buy |
25 Sep ‘24
11 months ago |
|
28
Zevra Therapeutics
ZVRA
$468M
| $8.21 | $25 |
205%
upside
| Buy |
24 Sep ‘24
11 months ago |
|
|
MESO
29
Mesoblast
MESO
$1.86B
| $15 | $12 |
20%
downside
| Buy |
24 Sep ‘24
11 months ago |
|
30
Rezolute
RZLT
$692M
| $8.08 | $10 |
24%
upside
| Buy |
6 Aug ‘24
1 year ago |
|
31
Actinium Pharmaceuticals
ATNM
$49.9M
| $1.60 | $5 |
213%
upside
| Buy |
6 Aug ‘24
1 year ago |
|
|
TAOX
32
Tao Synergies Inc. Common Stock
TAOX
$21.9M
| $6.24 | $14 |
124%
upside
| Buy |
11 Jul ‘24
1 year ago |
|
|
DWTX
33
Dogwood Therapeutics, Inc. Common Stock
DWTX
$9.36M
| $4.83 | $25 |
418%
upside
| Buy |
20 Jun ‘24
1 year ago |
|
34
Context Therapeutics
CNTX
$73.7M
| $0.8455 | $10 |
1,083%
upside
| Buy |
9 May ‘24
1 year ago |
|
35
Talphera
TLPH
$16.8M
| $0.8530 | $3 |
252%
upside
| Buy |
6 May ‘24
1 year ago |
|
36
ATAI Life Sciences
ATAI
$969M
| $4.89 | $6 |
23%
upside
| Buy |
3 Apr ‘24
1 year ago |
|
|
NEUP
37
Neuphoria Therapeutics Inc. Common Stock
NEUP
$24.4M
| $15.10 | $10 |
34%
downside
| Buy |
28 Sep ‘23
1 year ago |
|
38
Gain Therapeutics
GANX
$62.9M
| $1.71 | $10 |
485%
upside
| Buy |
12 Sep ‘23
2 years ago |
|
39
Genelux
GNLX
$134M
| $3.67 | $40 |
990%
upside
| Buy |
12 Sep ‘23
2 years ago |
|
40
VistaGen Therapeutics
VTGN
$107M
| $3.61 | $30 |
731%
upside
| Buy |
5 Sep ‘23
2 years ago |
|
41
Galmed Pharmaceuticals
GLMD
$7.51M
| $1.46 | $48 |
3,188%
upside
| Buy |
24 Jul ‘23
2 years ago |
|
|
HURA
42
TuHURA Biosciences, Inc. Common Stock
HURA
$126M
| $2.35 | $490 |
20,751%
upside
| Buy |
14 Jul ‘23
2 years ago |
|
|
IMMP
43
Immutep
IMMP
$252M
| $1.60 | $10 |
525%
upside
| Buy |
18 May ‘23
2 years ago |
|
44
Vertex Pharmaceuticals
VRTX
$101B
| $396.48 | $400 |
1%
upside
| Buy |
3 May ‘23
2 years ago |
|
45
Aprea Therapeutics
APRE
$9.38M
| $1.55 | $16 |
932%
upside
| Buy |
10 Mar ‘23
2 years ago |
|
46
Unicycive Therapeutics
UNCY
$77.2M
| $4.38 | $60 |
1,270%
upside
| Buy |
9 Mar ‘23
2 years ago |
|
47
Achieve Life Sciences
ACHV
$150M
| $3.12 | $8 |
156%
upside
| Buy |
16 Nov ‘22
2 years ago |
|
48
VolitionRX
VNRX
$65.7M
| $0.6370 | $5 |
685%
upside
| Buy |
23 Aug ‘22
3 years ago |
|
49
Femasys
FEMY
$12.5M
| $0.3740 | $5 |
1,237%
upside
| Buy |
17 Jun ‘22
3 years ago |
|
50
GeoVax Labs
GOVX
$17.7M
| $0.6890 | $90 |
12,962%
upside
| Buy |
23 May ‘22
3 years ago |
|